Survival benefit in patients after palliative resection vs non-resection colon cancer surgery

World Journal of Gastroenterology

Volumn 12, Issue 41, 2006, Pages 6634-6638

  Beham, Alexander ^a   Rentsch, M ^a   Pulmann K ^a   Mantouvalou, L ^a   Spatz, H ^a   Schlitt, H J ^a   Obed, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Colorectal cancer; Palliative surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BYPASS SURGERY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEMICOLECTOMY; HUMAN; ILEOSTOMY; ILEUS; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERITONEUM METASTASIS; PREOPERATIVE EVALUATION; RECTUM RESECTION; RISK FACTOR; SEX DIFFERENCE; SIGMOIDECTOMY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 33751305094     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i41.6634     Document Type: Article

References (19)

1. Devesa. JM, Morales V, Enriquez JM, Nuno J, Camunas J, Hernandez MJ, Avila C. Colorectal cancer. The bases for a comprehensive follow-up. Dis Colon Rectum 1988; 31: 636-652
2. Guba M, Bosserhoff AK, Steinbauer M, Abels C, Anthuber M, Buettner R, Jauch KW. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo. Br J Cancer 2000; 83: 1216-1222
3. Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer-is it worthwhile? Dis Colon Rectum 1997; 40:11-14
4. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, Millis JM, Posner MC. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000; 135: 530-534; discussion 534-535
5. Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33: 846-850
6. Ruo L, Gougoutas C, Paty PB, Guillern JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196: 722-728
7. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981; 24: 355-360
8. Law WL, Choi HK, Lee YM Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004; 47: 39-43
9. De Gregorio MA, Mainar A, Tejero E, Alfonso E, Gimeno MJ, Herrera M. Use of an introducer sheath for colonic stent placement. Eur Radiol 2002; 12: 2250-2252
10. Mainar A, De Gregorio Ariza. MA, Tejero E, Tobio R, Alfonso E, Pinto I, Herrera M, Fernandez JA. Acute colorectal obstruction: treatment with self-expandable metallic stents before scheduled surgery-results of a multicenter study. Radiology 1999; 210: 65-69
11. Tejero E, Fernandez-Lobato R, Mainar A, Montes C, Pinto I, Fernandez L, Jorge E, Lozano R. Initial results of a new procedure for treatment of malignant obstruction of the left colon. Dis Colon Rectum 1997; 40:432-436
12. Tejero E, Mainar A, Fernandez L, Tieso A, Cuezva JF, San Jose A. New procedure for relief of malignant obstruction of the left colon. Br J Surg 1995; 82: 34-35
13. Moran MR, Rothenberger DA, Lahr CJ, Buls JG, Goldberg SM. Palliation for rectal cancer. Resection? Anastomosis? Arch Surg 1987; 122: 640-643
14. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987; 5:1559-1565
15. Doroshow JH, Multhauf P, Leong L, Margolin K, Litchfield T, Akman S, Carr B, Bertrand M, Goldberg D, Blayney D. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990; 8: 491-501
16. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306: 752-755
17. Cazacu M, Oniu T, Lungoci C, Mihailov A, Cipak A, Klinger R, Weiss T, Zarkovic N. The influence of isorel on the advanced colorectal cancer. Cancer Biother Radiopharm 2003; 18: 27-34
18. Baars A, Buter J, Pinedo HM. Making use of the primary tumour. Bioessays 2003; 25: 79-86
19. Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Topham CA, Awad L, Jacques C, Herait P. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998; 352:1413-1418